Detalhe da pesquisa
1.
Impact of volemia at admission on the effect of collateral status on functional outcomes in patients undergoing endovascular thrombectomy.
Eur J Neurol
; 30(9): 2693-2699, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37255377
2.
Postoperative blood glucose increase is associated with futile recanalization in patients with successful thrombectomy: a retrospective study.
BMC Neurol
; 23(1): 447, 2023 Dec 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38114953
3.
Effect of Local Versus General Anesthesia in Breast-Conserving Surgery on Cancer Recurrence and Cost.
Cancer Control
; 29: 10732748221083078, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35459407
4.
Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer.
Int J Cancer
; 148(4): 941-949, 2021 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32720318
5.
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.
Int J Cancer
; 146(12): 3335-3342, 2020 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32037537
6.
BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.
Int J Cancer
; 146(11): 3044-3052, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31957001
7.
Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer.
Int J Cancer
; 146(2): 487-495, 2020 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31119730
8.
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
Breast Cancer Res Treat
; 179(3): 605-614, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31768816
9.
Germline mutation in DNA-repair genes is associated with poor survival in BRCA1/2-negative breast cancer patients.
Cancer Sci
; 110(10): 3368-3374, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31432574
10.
Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China.
Breast Cancer Res Treat
; 175(3): 749-754, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30895535
11.
Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Breast Cancer Res Treat
; 174(3): 639-647, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30607632
12.
RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
Int J Cancer
; 143(8): 1935-1942, 2018 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29726012
13.
Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers.
Cancer Sci
; 109(1): 166-173, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-29047188
14.
Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Breast Cancer Res Treat
; 169(1): 59-67, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29356917
15.
99mTc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis.
Breast Cancer Res Treat
; 168(2): 365-370, 2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-29209873
16.
Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients.
BMC Cancer
; 18(1): 662, 2018 Jun 18.
Artigo
Inglês
| MEDLINE | ID: mdl-29914420
17.
Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
PLoS Genet
; 11(5): e1005228, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25945795
18.
HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.
Cancer Sci
; 108(4): 671-677, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28164408
19.
TP53 mutations are associated with higher rates of pathologic complete response to anthracycline/cyclophosphamide-based neoadjuvant chemotherapy in operable primary breast cancer.
Int J Cancer
; 138(2): 489-96, 2016 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26238069
20.
Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.
Breast Cancer Res Treat
; 158(3): 455-62, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27393621